Gastroenterology Surgical Center, Mansoura University, Mansoura, 35516, Egypt.
Wadi Aldawaser Armed Forces Hospital, Wadi Aldawaser, Kingdom of Saudi Arabia, 18511.
Obes Surg. 2023 Oct;33(10):3237-3245. doi: 10.1007/s11695-023-06803-z. Epub 2023 Aug 25.
Postoperative nausea and vomiting (PONV) is a frequent unappealing laparoscopic sleeve gastrectomy (LSG) sequel. The study's purpose was to determine the prevalence, risk factors of PONV, and management of PONV after LSG.
This multicenter retrospective study included patients with morbid obesity who had LSG between January 2022 and April 2023. The age range for LSG was 16 to 65 years, and the eligibility requirements included morbid obesity according to international guidelines.
PONV was experienced by 74.6% of patients who underwent LSG at 6 h postoperative. Multivariate analysis revealed that female gender, smokers, preoperative GERD, gastropexy, and severity of pain were found to be independent risk variables of the development of PONV, while antral preservation, opioid-free analgesia, and intraoperative combined analgesia were found to be independent protective variables against the development of PONV. Combined intravenous ondansetron and metoclopramide improved 92.6% of patients who developed PONV. Dexamethasone and antihistamines drugs are given for 42 cases with persistent PONV after using intravenous ondansetron and metoclopramide. Pain management postoperatively by opioid-free analgesia managed PONV. Helicobacter pylori status has no role in the development of PONV after LSG.
Female gender, smoking, presence of preoperative GERD, gastropexy, and severity of pain were found to be independent risk variables of the development of PONV, while antral preservation, opioid-free analgesia, and intraoperative combined analgesia were observed to be independent protective factors against the occurrence of PONV. Combined intravenous ondansetron and metoclopramide improved PONV. Dexamethasone and antihistamines drugs are given for persistent PONV.
术后恶心呕吐(PONV)是腹腔镜袖状胃切除术(LSG)常见且令人不适的一种术后并发症。本研究旨在确定 LSG 后 PONV 的发生率、风险因素以及 PONV 的管理。
这是一项多中心回顾性研究,纳入了 2022 年 1 月至 2023 年 4 月期间接受 LSG 的肥胖症患者。LSG 的年龄范围为 16 至 65 岁,纳入标准为符合国际指南的肥胖症。
74.6%接受 LSG 的患者在术后 6 小时出现 PONV。多变量分析显示,女性、吸烟者、术前胃食管反流病(GERD)、胃固定术和疼痛严重程度是 PONV 发生的独立风险因素,而胃窦保留、无阿片类药物镇痛和术中联合镇痛是预防 PONV 发生的独立保护因素。静脉注射昂丹司琼和甲氧氯普胺联合治疗可改善 92.6%的 PONV 患者。对于静脉注射昂丹司琼和甲氧氯普胺后仍持续存在 PONV 的 42 例患者,给予地塞米松和抗组胺药物。术后无阿片类药物镇痛的疼痛管理可控制 PONV。LSG 后,幽门螺杆菌状态与 PONV 的发生无关。
女性、吸烟、术前存在 GERD、胃固定术和疼痛严重程度是 PONV 发生的独立风险因素,而胃窦保留、无阿片类药物镇痛和术中联合镇痛是预防 PONV 发生的独立保护因素。静脉注射昂丹司琼和甲氧氯普胺联合治疗可改善 PONV。对于持续存在的 PONV,给予地塞米松和抗组胺药物。